124 related articles for article (PubMed ID: 38422806)
21. Interobserver variability in application of the revised Sydney classification for gastritis.
Guarner J; Herrera-Goepfert R; Mohar A; Sanchez L; Halperin D; Ley C; Parsonnet J
Hum Pathol; 1999 Dec; 30(12):1431-4. PubMed ID: 10667420
[TBL] [Abstract][Full Text] [Related]
22. Role of intestinal metaplasia subtyping in the risk of gastric cancer in Korea.
Kang KP; Lee HS; Kim N; Kang HM; Park YS; Lee DH; Choe G; Kim JS; Jung HC; Song IS
J Gastroenterol Hepatol; 2009 Jan; 24(1):140-8. PubMed ID: 18713298
[TBL] [Abstract][Full Text] [Related]
23. Cytokeratin expression patterns in noncardia, intestinal metaplasia-associated gastric adenocarcinoma: implication for the evaluation of intestinal metaplasia and tumors at the esophagogastric junction.
Shen B; Ormsby AH; Shen C; Dumot JA; Shao YW; Bevins CL; Gramlich TL
Cancer; 2002 Feb; 94(3):820-31. PubMed ID: 11857318
[TBL] [Abstract][Full Text] [Related]
24. Impact of the angulus biopsy for the detection of gastric preneoplastic conditions and gastric cancer risk assessment.
Varbanova M; Wex T; Jechorek D; Röhl FW; Langner C; Selgrad M; Malfertheiner P
J Clin Pathol; 2016 Jan; 69(1):19-25. PubMed ID: 26163538
[TBL] [Abstract][Full Text] [Related]
25. Clinical significance of spasmolytic polypeptide-expressing metaplasia and intestinal metaplasia in Epstein-Barr virus-associated and Epstein-Barr virus-negative gastric cancer.
Zhang Y; Chen JN; Dong M; Zhang ZG; Zhang YW; Wu JY; Du H; Li HG; Huang Y; Shao CK
Hum Pathol; 2017 May; 63():128-138. PubMed ID: 28300576
[TBL] [Abstract][Full Text] [Related]
26. Does Adding a Cardia Biopsy Improve Gastric Intestinal Metaplasia Detection Rate by the Sydney System Protocol?
Soltani G; Saberzadeh-Ardestani B; Sotoudeh M; Naseri-Moghaddam S; Derakhshan MH; Saffar H; Kasaeian A; Chavoshi M; Sima A
Arch Iran Med; 2022 Jun; 25(6):394-398. PubMed ID: 35943019
[TBL] [Abstract][Full Text] [Related]
27. Differences in diagnostic criteria for gastric carcinoma between Japanese and western pathologists.
Schlemper RJ; Itabashi M; Kato Y; Lewin KJ; Riddell RH; Shimoda T; Sipponen P; Stolte M; Watanabe H; Takahashi H; Fujita R
Lancet; 1997 Jun; 349(9067):1725-9. PubMed ID: 9193382
[TBL] [Abstract][Full Text] [Related]
28. Recognition of goblet cells upon endocytoscopy indicates the presence of gastric intestinal metaplasia.
Chiu PW; Ng EK; To KF; Teoh AY; Lam CC; Chan FK; Sung JJ; Lau JY
Dig Endosc; 2014 Jan; 26(1):52-6. PubMed ID: 23551261
[TBL] [Abstract][Full Text] [Related]
29. Low frequency of intestinal metaplasia in gastric biopsies from Mexican patients: a comparison with Japanese and Swedish patients.
Rubio CA; Jessurun J
Jpn J Cancer Res; 1992 May; 83(5):491-4. PubMed ID: 1618699
[TBL] [Abstract][Full Text] [Related]
30. Expression of GCRG213p, LINE-1 endonuclease variant, significantly different in gastric complete and incomplete intestinal metaplasia.
Duan X; Lian H; Li J; Wu B; Wang W; Wu T; Wang C; Dou Y; Zhou Z; Wang B; Xue L; Wang G
Diagn Pathol; 2019 Jun; 14(1):61. PubMed ID: 31221180
[TBL] [Abstract][Full Text] [Related]
31. Incomplete Intestinal Metaplasia of the Stomach Is more Related to Bile Reflux than Chronic Gastritis.
Younes M; Arora A; DuPont AW; Cash BD; Ertan A
Ann Clin Lab Sci; 2023 Sep; 53(5):696-700. PubMed ID: 37945016
[TBL] [Abstract][Full Text] [Related]
32. Intestinal metaplasia and its variants in the gastric mucosa of Portuguese subjects: a comparative analysis of biopsy and gastrectomy material.
Silva S; Filipe MI
Hum Pathol; 1986 Oct; 17(10):988-95. PubMed ID: 3759069
[TBL] [Abstract][Full Text] [Related]
33. Histological diagnosis of precancerous lesions of the stomach: a reliability study.
Plummer M; Buiatti E; Lopez G; Peraza S; Vivas J; Oliver W; Muñoz N
Int J Epidemiol; 1997 Aug; 26(4):716-20. PubMed ID: 9279602
[TBL] [Abstract][Full Text] [Related]
34. Regulation of apoptosis is impaired in atrophic gastritis associated with gastric cancer.
Rosania R; Varbanova M; Wex T; Langner C; Bornschein J; Giorgio F; Ierardi E; Malfertheiner P
BMC Gastroenterol; 2017 Jun; 17(1):84. PubMed ID: 28662697
[TBL] [Abstract][Full Text] [Related]
35. Intestinal metaplasia of the stomach and esophagus: an immunohistochemical study of 60 cases including comparison with normal and inflamed intestinal mucosa.
Chlumská A; Mukenšnabl P; Mareček P; Zámečník M
Cesk Patol; 2014 Jul; 50(3):141-8. PubMed ID: 25186595
[TBL] [Abstract][Full Text] [Related]
36. Utility of subtyping intestinal metaplasia as marker of gastric cancer risk. A review of the evidence.
González CA; Sanz-Anquela JM; Gisbert JP; Correa P
Int J Cancer; 2013 Sep; 133(5):1023-32. PubMed ID: 23280711
[TBL] [Abstract][Full Text] [Related]
37. Acetic acid chromoendoscopy for determining the extent of gastric intestinal metaplasia.
Song KH; Hwang JA; Kim SM; Ko HS; Kang MK; Ryu KH; Koo HS; Lee TH; Huh KC; Choi YW; Kang YW
Gastrointest Endosc; 2017 Feb; 85(2):349-356. PubMed ID: 27515128
[TBL] [Abstract][Full Text] [Related]
38. Gastric intestinal metaplasia: Long-term follow-up results.
Rakici H; Uyanik E; Rakici IM; Polat HB; Akdogan RA; Aydin G; Ayvaz MA; Bedir R
Niger J Clin Pract; 2022 Mar; 25(3):315-324. PubMed ID: 35295055
[TBL] [Abstract][Full Text] [Related]
39. Magnification chromoendoscopy for the diagnosis of gastric intestinal metaplasia and dysplasia.
Dinis-Ribeiro M; da Costa-Pereira A; Lopes C; Lara-Santos L; Guilherme M; Moreira-Dias L; Lomba-Viana H; Ribeiro A; Santos C; Soares J; Mesquita N; Silva R; Lomba-Viana R
Gastrointest Endosc; 2003 Apr; 57(4):498-504. PubMed ID: 12665759
[TBL] [Abstract][Full Text] [Related]
40. The diagnostic utility of narrow band imaging magnifying endoscopy in clinical practice in a population with intermediate gastric cancer risk.
Ang TL; Fock KM; Teo EK; Tan J; Poh CH; Ong J; Ang D
Eur J Gastroenterol Hepatol; 2012 Apr; 24(4):362-7. PubMed ID: 22198222
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
